Results 151 to 160 of about 560,117 (294)

Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward. [PDF]

In Vivo
Kanie T, Mizuno T, Koseki T, Hanamoto A, Sawano H, Tomida M, Kakumae Y, Hayashi T, Matsuoka H, Usui M, Yamada S.   +10 more
europepmc   +1 more source

Probes for Narcotic Receptor Mediated Phenomena. 41. Unusual Inverse μ-Agonists and Potent μ-Opioid Antagonists by Modification of the N-Substituent in Enantiomeric 5-(3-Hydroxyphenyl)morphans [PDF]

, 2011
Kejun Cheng, Yong Sok Lee, Richard B. Rothman, Christina M. Dersch, Ross W. Bittman, Arthur E. Jacobson, Kenner C. Rice   +6 more
openalex   +1 more source

Accidental protonitazene intoxication: clinical management and detection of a novel opioid. [PDF]

BMJ Case Rep
Meltzer J, Boucher A, Cohen S, Morere J.
europepmc   +1 more source

Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity [PDF]

, 2012
Malliga R. Iyer, Yong Sok Lee, Jeffrey R. Deschamps, Christina M. Dersch, Richard B. Rothman, Arthur E. Jacobson, Kenner C. Rice   +6 more
openalex   +1 more source

Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. [PDF]

J Addict Med
Black AC, Becker WC.
europepmc   +1 more source

Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference. [PDF]

Neuropsychopharmacol Rep
Ide S, Iwase N, Arai K, Kojima M, Ushiyama S, Ikeda K.   +5 more
europepmc   +1 more source

Paravertebral blocks and enhanced recovery after surgery protocols in breast reconstructive surgery: Patient selection and perspectives [PDF]

, 2018
Myckatyn, Terence M, Parikh, Rajiv P
core   +1 more source

Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.

Health Technol Assess
Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H, Evans BA, Fuller G, Hoskins R, Hughes J, Jones J, Jones M, Johnston S, Long J, Moore C, Parab R, Pilbery R, Sampson FC, Watkins A.   +18 more
europepmc   +1 more source

Community-Originated Research to Identify Access Gaps in Over-the-Counter Naloxone Availability in Connecticut Pharmacies. [PDF]

Harm Reduct J
Hill K, Canning P, Canning Z, Breen C, Evans L, Jenkins M, Nickel M, Plourd K, Heimer R.   +8 more
europepmc   +1 more source

HOMOBENZOMORPHAN COMPOUNDS WITH A POTENT NARCOTIC ANTAGONIST PROPERTY

, 1974
Seiichi Nurimoto, Shogo Suzuki, Goro Hayashi, Mikio Takeda   +3 more
openalex   +1 more source